Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457 (cas 107188-66-9)
-
Add time:08/13/2019 Source:sciencedirect.com
Dopamine D2 receptor occupancy by antipsychotic drugs has been measured with positron emission tomography (PET) by comparing the binding potential (BP) values before and after drug administration. This occupancy has been found to be related to clinical effects and side effects. In this study, we evaluated the uncertainty of the quantitative analysis for estimating the dopamine D2 receptor occupancy by antipsychotics in simulation and human studies of [11C]raclopride and for the high affinity ligand [11C]FLB 457. Time–activity curves of [11C]raclopride and [11C]FLB 457 were simulated, and the reliability of BP estimated by a simplified reference tissue model and the calculated occupancy were investigated for various noise levels, BP values, and scan durations. Then, in the human PET study with and without antipsychotics, the uncertainty of BP and occupancy estimates and the scan duration required for a reliable estimation were investigated by a bootstrap approach. Reliable and unbiased estimates of [11C]raclopride BPND could be obtained with recording as short as 32 min, with the relative standard deviation (SD) of the striatal occupancy remaining less than 10%. Conversely, in [11C]FLB 457 studies, the mean value increased and SD of the temporal cortex and thalamus exceeded 10% when the scan duration was shorter than 60 min. These results demonstrated that dopamine D2 receptor occupancy by antipsychotics can be estimated precisely with an optimal scan duration with [11C]raclopride and [11C]FLB 457.
We also recommend Trading Suppliers and Manufacturers of FLB 457 (cas 107188-66-9). Pls Click Website Link as below: cas 107188-66-9 suppliers
Prev:Biodistribution and radiation dosimetry in humans of [11C]FLB 457 (cas 107188-66-9), a positron emission tomography ligand for the extrastriatal dopamine D2 receptor☆
Next:Research reportExtrastriatal D2 and striatal D2 receptors in depressive illness: Pilot PET studies using [11C]FLB 457 (cas 107188-66-9) and [11C]raclopride) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- [11C]Cyclopropyl-FLB 457 (cas 107188-66-9): A PET radioligand for low densities of dopamine D2 receptors08/21/2019
- A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 (cas 107188-66-9) and [11C]WAY 10063508/20/2019
- Regular ArticleError Analysis for Quantification of [11C]FLB 457 (cas 107188-66-9) Binding to Extrastriatal D2 Dopamine Receptors in the Human Brain08/19/2019
- Regular ArticlePET Mapping of Extrastriatal D2-like Dopamine Receptors in the Human Brain Using an Anatomic Standardization Technique and [11C]FLB 457 (cas 107188-66-9)08/18/2019
- Original articlePreparation of [76Br]FLB 457 (cas 107188-66-9) and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET08/17/2019
- Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: A [11C]FLB 457 (cas 107188-66-9) PET study08/16/2019
- Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study08/15/2019
- Research reportExtrastriatal D2 and striatal D2 receptors in depressive illness: Pilot PET studies using [11C]FLB 457 (cas 107188-66-9) and [11C]raclopride08/14/2019
- Biodistribution and radiation dosimetry in humans of [11C]FLB 457 (cas 107188-66-9), a positron emission tomography ligand for the extrastriatal dopamine D2 receptor☆08/12/2019


